News and Updates

African institutions are spearheading Phase 1 trials for a Bundibugyo ebolavirus vaccine, marking a vital step toward regional health security and equity.

Moderna has started Phase 1 clinical trials for an mRNA Ebola vaccine targeting the Sudan strain. Learn about this breakthrough in infectious disease care.

Considering a cancer clinical trial? Learn how to navigate inclusion criteria, the consent process, and key questions to ask your oncologist before joining.

QuantHealth secures $45M in Series B funding to scale its AI-driven clinical trial simulation platform, aimed at reducing drug development risks and costs.

Could semaglutide treat alcohol addiction? New research shows promising reductions in heavy drinking days, suggesting a new path for AUD treatment.

The FDA is revolutionizing clinical trials through decentralized methods and adaptive designs to accelerate drug development and patient access.

Radiopharm Theranostics raises $16M following successful clinical trial milestones in radiopharmaceutical oncology research. Learn about their latest progress.

An FDA advisory panel has recommended expanded use for peptide-based therapies, signaling a major shift in treatment for chronic metabolic conditions.

Boston Scientific has issued a Class I recall for specific catheters due to risks of separation. Learn the critical safety steps for clinical teams.

New research reveals that Calocurb effectively triggers GLP-1 for fat loss while protecting lean muscle mass. Learn how this supplement aids metabolic health.